Sahlgrenska University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

    Journal of Clinical Endocrinology and Metabolism, Vol. 107, Núm. 9, pp. 2644-2651